1. Home
  2. ACCO vs RLMD Comparison

ACCO vs RLMD Comparison

Compare ACCO & RLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Acco Brands Corporation

ACCO

Acco Brands Corporation

HOLD

Current Price

$3.92

Market Cap

346.1M

ML Signal

HOLD

Logo Relmada Therapeutics Inc.

RLMD

Relmada Therapeutics Inc.

HOLD

Current Price

$4.10

Market Cap

319.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACCO
RLMD
Founded
1893
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Publishing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
346.1M
319.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ACCO
RLMD
Price
$3.92
$4.10
Analyst Decision
Buy
Strong Buy
Analyst Count
1
3
Target Price
$6.00
$9.00
AVG Volume (30 Days)
587.2K
541.7K
Earning Date
02-19-2026
11-13-2025
Dividend Yield
7.58%
N/A
EPS Growth
N/A
N/A
EPS
0.43
N/A
Revenue
$1,544,000,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$3.53
N/A
P/E Ratio
$9.17
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.20
$0.24
52 Week High
$5.68
$5.12

Technical Indicators

Market Signals
Indicator
ACCO
RLMD
Relative Strength Index (RSI) 53.89 51.73
Support Level $3.93 $3.78
Resistance Level $4.11 $4.53
Average True Range (ATR) 0.10 0.31
MACD -0.01 -0.02
Stochastic Oscillator 46.58 57.98

Price Performance

Historical Comparison
ACCO
RLMD

About ACCO Acco Brands Corporation

ACCO Brands Corp designs, manufactures, and markets consumer and business products. It operates through two segments: ACCO Brands Americas, and ACCO Brands International. The company offers school notebooks, janitorial supplies, and whiteboards; storage and organization products, sheet protectors, and indexes, and punching products; computer accessories and others used in schools, homes, and businesses. The company markets and sells its products through various channels, including mass retailers; e-tailers; discount, and variety chains; and warehouse clubs. It generates maximum profit from ACCO Brands America segment.

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its key product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.

Share on Social Networks: